News
News
PublISHED ON
UpDATED ON
Sweden participates in clinical WHO study
Sweden is participating in a major clinical study conducted by WHO, aimed at testing a number of antiviral medicines on patients around the world who are being treated for COVID-19.
Because more than 100 countries are taking part in the WHO study Solidarity Trial, the patient base is large. This makes it quicker to see whether any of the preparations are effective, and can begin to be used to treat the disease.
The Swedish Government recently appointed Soo Aleman, Consultant Physician at the Karolinska University Hospital and Associate Professor at Karolinska Institutet, to be the national coordinator for the Swedish part of the study. The Swedish Research Council will fund Swedish participation, as soon as the investment is formalized in the regulatory letter.
“It is important for Sweden to be part of the international study. Patients in Sweden who have suffered severe COVID-19 can now get access to potentially effective medicines. In the long term we will obtain greater knowledge of what is effective, which will also benefit patients who are not part of the study,” says Jan-Ingvar Jönsson, Secretary General of the Scientific Council for Medicine and Health and Clinical Therapy Research at the Swedish Research Council.
About the studie Solidarity trial on WHO´s website
External link.
RELATERAT INNEHÅLL
MORE WITHIN THE SAME SUBJECT AREA
-
Activity |
Published 29 November 2021
The Swedish Research Council arrange a seminar on the upcoming evaluation of the quality of clinical research conducted in the regions that are subject to the ALF agreement. The purpose of the seminar is to inform about the upcoming evaluation. The r...
-
News |
Published 19 November 2021
We have now decided on the dates for 40 or our calls next year. Many of calls are recurrent, but some will be issued for the first time. The new calls are shown in the list below. More calls will be added.
-
News |
Published 15 November 2021
The Swedish Research Council is allocating 50 million SEK to 14 research projects into post-COVID syndrome. The research shall contribute to developing knowledge within health and medical care, and improving diagnosis and therapy alternatives for pat...